NKGen Biotech, Inc. Common Stock (NKGN) earnings · $22.4M cap
NKGen Biotech, Inc. Common Stock (NKGN) is a biotechnology company listed on US.
This NKGN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NKGN revenue for 2023-12-31 was $0. Net income was -$83.0M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. NKGN currently screens at market cap $22.4M.
When the next NKGN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2022-12-31 to 2023-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full NKGN research stays on the stock page; the tape stays on the quote page.
Not investment advice.